Endocrine Gland Neoplasms  >>  linsitinib (ASP7487)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
linsitinib (ASP7487) / Sling Therap
NCT01600807: OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas

Withdrawn
1/2
0
US
Gemcitabine, Erlotinib, OSI-906, Gemzaar, Tarceva, Gemcitabine, Erlotinib
Dana-Farber Cancer Institute
Pancreatic Cancer, Metastatic
 
 

Download Options